Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Valneva (Group)

Valneva is a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs. Valneva’s portfolio includes two commercial vaccines for travelers: IXIARO®/JESPECT® indicated for the prevention of Japanese encephalitis and DUKORAL® indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by ETEC. The Company has various clinical-stage vaccines in development including unique vaccines against Lyme disease and chikungunya. Valneva has operations in Austria, Sweden, the United Kingdom, France, Canada and the US with approximately 490 employees. *

 

Period Start 2013-05-28 merged
  Predecessor Vivalis (Group)
Products Industry avian (bird) production technology (transgenic)
  Industry 2 vaccine
Persons Person Lingelbach, Thomas (Intercell 201106– CEO before COO before 2001– Chiron Behring)
  Person 2 Grimaud, Franck (Vivalis 200702 CEO)
     
Region Region Lyon
  Country France
  Street 6 rue Alain Bombard
Campus Bio-Quest
  City 44800 Saint-Herblain
    Address record changed: 2020-12-02
     
Basic data Employees E: 501 to 1,000 (2021-09-30)
  Currency EUR
  Annual sales 110,321,000 (revenues, total, consolidated (2020) 2020-12-31)
  Profit -64,393,000 (2020-12-31)
  Cash 329,766,000 (2021-06-30)
     
    * Document for �About Section�: Valneva S.E.. (1/9/20). "Press Release: Valneva Expands its Commercial Operations with the Opening of its French Commercial Office". Saint-Herblain.
     
   
Record changed: 2021-10-30

Advertisement

Picture [iito] No Tracking 650x100px

More documents for Valneva (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Bionnale the Annual Life Sciences Event 650x80px




» top